A detailed history of Quantamental Technologies LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Quantamental Technologies LLC holds 2,196 shares of UTHR stock, worth $788,825. This represents 0.47% of its overall portfolio holdings.

Number of Shares
2,196
Holding current value
$788,825
% of portfolio
0.47%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $465,156 - $545,135
2,196 New
2,196 $496,000
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $578,970 - $798,655
-3,312 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$166.16 - $213.96 $550,321 - $708,635
3,312 New
3,312 $594,000
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $198,594 - $241,782
-2,536 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$74.85 - $85.99 $109,430 - $125,717
-1,462 Reduced 36.57%
2,536 $202,000
Q2 2019

Aug 12, 2019

BUY
$76.06 - $120.81 $304,087 - $482,998
3,998 New
3,998 $312,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.